Purchase Order DJBP0412PB270009
- Not listed
- This federal contract award, valued at $57,790.55, was made by the Federal Medical Center Rochester, a civilian agency, to Mayo Clinic, a renowned non-profit academic medical center, to provide comprehensive medical services described as "mission critical" through a firm-fixed price purchase order. The contract has no set-aside designation and is associated with a larger National Cancer Institute multiple-award indefinite delivery/indefinite quantity (IDIQ) contract valued at $9.9...
- This federal contract award was issued by the Federal Medical Center Rochester, a civilian agency, to Mayo Clinic, a private non-profit academic medical center. The contract, valued at $711,003.29, is for the delivery of comprehensive medical services to the agency's facility in Rochester, Minnesota. The contract is a firm-fixed price delivery order with no set-aside designation. Additionally, Mayo Clinic holds a multiple-award indefinite delivery/indefinite quantity (IDIQ) contract with the...
- This is a firm-fixed price purchase order contract awarded to Mayo Clinic, a non-profit academic medical center, by the Federal Medical Center Rochester, a civilian agency. The contract, valued at $31,668.35, is for the provision of comprehensive medical services to the agency from July 2024 through November 2024. Mayo Clinic has a long history of providing healthcare, research, and education services to federal agencies, including the National Cancer Institute and Defense Health Agency, through...
- This is a firm-fixed price delivery order contract awarded by the Federal Medical Center (FMC) Rochester, a civilian agency, to Mayo Clinic for the provision of comprehensive medical services. The award has a base year value of $9,577,347.96 from July 1, 2015 to June 30, 2016, with a total ceiling value of $1,049,531.16. The contract does not have a set-aside designation. Mayo Clinic, a renowned non-profit academic medical center, will leverage its expertise in clinical care, research, and...
- This is a federal contract award issued by the Federal Medical Center Rochester, a civilian agency, to Mayo Clinic, a renowned non-profit academic medical center. The contract, valued at $10,559.25, is for the provision of comprehensive medical services including telehealth for the period from October 2024 through December 2024. The contract is a firm-fixed price purchase order and does not have a set-aside designation, reflecting Mayo Clinic's status as a large institution. Mayo Clinic has a...
- This federal contract award is for comprehensive medical services to be provided by Mayo Clinic to the Federal Medical Center Rochester, a civilian federal agency. The contract, valued at $60,441.45, is a firm-fixed-price purchase order with a period of performance ending on July 31, 2025. It does not utilize any set-aside designations. Mayo Clinic, a renowned non-profit academic medical center, is the prime contractor for this award. The contract covers a range of medical services, including...
- This federal contract award, valued at $11,336.20, was issued by the Federal Medical Center Rochester, a civilian agency, to the Mayo Clinic, a non-profit academic medical center. The contract is for comprehensive medical services, including telehealth, for the agency. This is a firm-fixed price purchase order contract that was not set aside for a specific business type. The Mayo Clinic has a long history of providing medical services, conducting research, and educating healthcare professionals....
- This federal contract award was issued by the Federal Medical Center Rochester, a civilian agency, to Mayo Clinic, a large non-profit academic medical center. The $958,367.61 firm-fixed-price purchase order is for comprehensive medical services to be provided by Mayo Clinic from June 2024 to October 2024. The contract was not set aside for any special designation. Mayo Clinic has a long history of providing medical research, healthcare, and education services to various federal agencies...
- This is a $78,481.66 firm-fixed-price purchase order awarded by the Federal Medical Center Rochester, a civilian agency, to Mayo Clinic, a renowned non-profit academic medical center, for comprehensive medical services including after-hours physician coverage. The award, which does not have a set-aside designation, runs through March 31, 2025. Mayo Clinic has a long history of providing a wide range of biomedical research, healthcare, and education services to federal agencies through prime...
- This federal contract award, valued at $12,858.25, was issued by the Federal Medical Center Rochester, a civilian agency, to Mayo Clinic, a renowned non-profit academic medical center. The contract is for the provision of "mission critical" comprehensive medical services, including telehealth, for FY25. The contract is a firm-fixed-price purchase order and does not utilize any set-aside designation. Mayo Clinic has extensive experience providing specialized medical services to...
This federal contract award to Mayo Clinic is a Firm Fixed Price Purchase Order contract worth $928,843.33, awarded by the Federal Medical Center Rochester, a civilian agency. The contract was awarded on June 1, 2015 with a performance period through September 30, 2016. It does not have a set-aside designation. Mayo Clinic, a renowned non-profit academic medical center, is the prime contractor on this contract. The contract supports various federal initiatives aimed at advancing medical knowledge and improving patient care. Mayo Clinic has provided critical support to agencies like the National Cancer Institute (NCI) and Defense Health Agency through previous prime contracts, grants, and subcontractor arrangements. Notably, Mayo Clinic holds a multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the NCI, valued at up to $9.9 million, to provide research and development services supporting preclinical pharmacokinetic and pharmacology evaluations of cancer therapeutic agents. This contract enables the NCI to efficiently access Mayo Clinic's expertise in cancer research and drug development over multiple years, facilitating the advancement of promising cancer therapies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 7 | Funding Only Action | $25.0k | 1/29/16 | |
| 6 | Funding Only Action | $0 | 12/23/15 | |
| 5 | Funding Only Action | ($2k) | 10/29/15 | |
| 4 | Funding Only Action | ($152k) | 9/25/15 | |
| 3 | Funding Only Action | $11.8k | 8/28/15 |